Cytek Biosciences, Inc. (CTKB) Q1 2026 Earnings Call Transcript
Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Beats Revenue Estimates
Cytek Biosciences Reports First Quarter 2026 Financial Results
Analysts Set Cytek Biosciences, Inc. (NASDAQ:CTKB) PT at $5.38
Cytek Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026
Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact
Cytek Biosciences Highlights Aurora Evo, Recurring Revenue Growth and 2026 Outlook at TD Cowen Conference
Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue Estimates
Cytek Biosciences, Inc. (CTKB) Q4 2025 Earnings Call Transcript
Cytek Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook
Cytek Biosciences to participate at the TD Cowen 46th Annual Health Care Conference
Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
Cytek Biosciences, Inc. (CTKB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Cytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue Results
Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives Average Rating of “Hold” from Analysts
Bank of Montreal Can Boosts Stock Position in Cytek Biosciences, Inc. $CTKB
Cytek Biosciences Is A Speculative Buy On Recurring Revenue Growth
TIME Recognizes Cytek® Biosciences as One of America's Growth Leaders of 2026
Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year
Cytek Biosciences to Participate in Upcoming Investor Conferences
Cytek Biosciences, Inc. (CTKB) Q3 2025 Earnings Call Transcript
Cytek Biosciences, Inc. (CTKB) Reports Q3 Loss, Tops Revenue Estimates
Cytek Biosciences Reports Third Quarter 2025 Financial Results
Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry
Cytek Biosciences to Report Third Quarter 2025 Financial Results on November 5, 2025
Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth
Cellares Selects Five Best-in-Class Technology Providers, Tecan, Advanced Instruments, Cytek Biosciences, Slingshot Biosciences and AltemisLab, to Expand Cell Q's Capabilities in Meeting Demands for Commercial Scale Cell Therapy Quality Control
Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA
Cytek Biosciences, Inc. (CTKB) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
Cytek Biosciences to Participate in Upcoming Investor Conferences
Cytek Biosciences, Inc. (CTKB) Q2 2025 Earnings Call Transcript
Cytek Biosciences, Inc. (CTKB) Beats Q2 Earnings Estimates
Cytek Biosciences Reports Second Quarter 2025 Financial Results
Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer
Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference
Cytek Biosciences, Inc. (CTKB) Q1 2025 Earnings Call Transcript
Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Lags Revenue Estimates
Cytek Biosciences Reports First Quarter 2025 Financial Results
Cytek Biosciences: With Growth, Low Debt, And A Positive Long-Term Outlook, Is It Undervalued?
Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025
Why Cytek Biosciences Should Beat Q1 Earnings Expectations
Cytek Biosciences to Report First Quarter 2025 Financial Results on May 8, 2025
Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System
Cytek Biosciences, Inc. (CTKB) Q4 2024 Earnings Conference Call Transcript
Cytek Biosciences, Inc. (CTKB) Tops Q4 Earnings Estimates
Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook
Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
Cytek Biosciences to Participate in Upcoming Investor Conferences
Upgrading Cytek Biosciences Stock On An Upcoming Catalyst
Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference